COLL Collegium Pharmaceutical Inc.

Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference

Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference

STOUGHTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) --  (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in a fireside chat at the 23rd Annual Needham Healthcare Conference being held virtually from April 8-11, 2024.

Details of the event are as follows:

Fireside Chat Date and Time: Wednesday, April 10, 2024, at 3:45 p.m. ET

The fireside chat will be webcast live and can be accessed from the Investors section of the Company's website: . A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

About Collegium Pharmaceutical, Inc.

Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at .

Investor Contact:

Christopher James, M.D.

Vice President, Investor Relations

Media Contact:

Marissa Samuels

Vice President, Corporate Communications



EN
03/04/2024

Underlying

COLLCollegium Pharmaceutical Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Collegium Pharmaceutical Inc.

 PRESS RELEASE
Free
COLL Collegium Pharm...

Collegium Announces Poster Presentations at the American Academy of Ch...

Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences STOUGHTON, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: COLL) today announced it will have poster presentations highlighting real-world data from its differentiated neuropsychiatry product, Jornay PM, (methylphenidate HCl), a central nervous system (CNS) stimulant for the treatment of attention deficit hyperactivity disorder (ADHD) in people 6 years of age and older at the American Academy of Child & Adolescent Psychiatry (AACAP) and Neur...

4h / 10m 1 EN
 PRESS RELEASE
Free
COLL Collegium Pharm...

Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ri...

Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing – Collegium to Ring Nasdaq Opening Bell on October 14, 2025 – STOUGHTON, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: COLL) today announced that its management team will ring the Nasdaq opening bell on October 14, 2025 at 9:30 a.m. ET in celebration of its 10-year anniversary as a publicly traded company on the Nasdaq Stock Market. “Since its inception, Collegium has remained dedicated to improving the lives of patients with serious medical conditions. That commitment has fueled both our growth and the im...

October 13, 2025 1 EN
Free Trial
COLL Collegium Pharm...

Collegium Pharmaceutical Inc: 1 director

A director at Collegium Pharmaceutical Inc sold 17,478 shares at 38.424USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

COLL COLLEGIUM PHARMACEUTICAL INC.
09/03/25 September 3, 2025 1 EN
 PRESS RELEASE
Free
COLL Collegium Pharm...

Collegium to Participate in Upcoming Investor Conferences

Collegium to Participate in Upcoming Investor Conferences STOUGHTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) --  (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: 2025 Wells Fargo Healthcare ConferenceThursday, September 4, 2025Boston, MA Morgan Stanley 23rd Annual Global Healthcare ConferenceFireside Chat Date and Time: Monday, September 8, 2025 at 2:35 p.m. ETNew York, NY A live webcast of the fireside chat will be available via the Investors section of the Company's website: . A replay of the webcast will be archived on the Comp...

August 28, 2025 1 EN
 PRESS RELEASE
Free
COLL Collegium Pharm...

Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Ann...

Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting STOUGHTON, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: COLL) today announced it will present nine posters showcasing real-world data from its differentiated pain portfolio at PAINWeek 2025, taking place in Las Vegas, NV, September 2-5, 2025. The posters will highlight real-world data from the company’s portfolio of pain treatments and reflect Collegium’s continued commitment to responsible pain management. “We are pleased to present this new research to the pain care community,” said Thomas Smith, M....

August 25, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch